
In part 2 of this series, Dr. Mallampalli sat down with Drug Topics® to discuss biosimilars as a treatment option for chronic health conditions and their impact on women’s health.

In part 2 of this series, Dr. Mallampalli sat down with Drug Topics® to discuss biosimilars as a treatment option for chronic health conditions and their impact on women’s health.

In the rapidly evolving health and wellness space of cannabis and hemp-derived products, Stephanie Rech and Chris Howard of E-Alternative Solutions discuss the biggest questions from pharmacists, retailers, and consumers on CBD.

In an exclusive interview with Drug Topics, Beth Mitchell, senior director of government affairs at AmerisourceBergen, explores the ways that pharmacists can take action on legislation that affects their practice.


In part 2 of this interview with Drug Topics®, Angela Fusaro MD, MBA, CEO and cofounder of Physician 360, a telemedicine program that connects patients to health care providers, discusses how independent pharmacies can use telemedicine to play an expanded role in patient care while competing with larger chains and online pharmacies.

"I just hope that now that the bar has been raised, as a profession, we're able to really advocate for removal of the long term barriers and continue to focus on practice expansion."

"Patient care doesn't stop with COVID-19"

In part 2 of our interview, Jason Ausili, PharmD, speaks to the challenges of COVID-19 vaccination processes and dives into technology solutions for these workflow barriers.
Please check back later for more content.




